REQUEST FOR PROPOSALS
Frontotemporal Dementia Drug Discovery Program
|
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) seek to accelerate and support drug discovery for FTD and related dementias through this Request for Proposals (RFP). Research investigating the pathologic mechanisms of neurodegeneration in frontotemporal dementia (FTD) and related disorders has advanced recently, creating new potential targets for drug discovery.
Examples of programs appropriate for this RFP include, but are not limited to:
Mechanism(s) of Support ADDF/AFTD will provide individual grants for one-year duration with the possibility of follow-on funding. Applications may be submitted by non-profit academic institutions and for-profit biotechnology companies, both public and private, worldwide. Collaborative teams of neuroscientists and researchers in drug discovery disciplines such as medicinal chemistry and drug delivery are also encouraged to apply. Review Process The deadline date for applications is October 1, 2009. Applications will be confidentially reviewed by ADDF and an external Scientific Review Committee, including AFTD scientific advisors. Applications from biotechnology companies will also be reviewed by ADDF’s external Business Advisory Board. Award winners will be publicly announced in Spring 2010.Application Procedure ADDF and AFTD seek to work with prospective applicants to ensure appropriate and qualified programs of interest that meet their partnership objectives. An inquiry with ADDF scientific staff is therefore encouraged prior to application submission. To further discuss scientific or financial aspects of proposals, please contact: Diana Shineman, PhD Assistant Director of Scientific Affairs 212-901-8007 All applications must be submitted electronically at www.alzdiscovery.org. For more information regarding the application process, please contact: Adam Liebling Senior Grants Manager 212-901-8005 |